Answers are grounded in this paper and cite their sources.
Case report reveals occult central nervous system leukemia presenting as complex headaches, highlighting the need for clinical vigilance despite unremarkable neuroimaging.
The role of acute myelogenous leukemia (AML) in affecting the central nervous system (CNS) is not well-defined, with reported incidence rates varying widely. Central nervous system involvement is typically regarded as rare during the initial stages of AML. We present a case of a 28-year-old woman who had AML with CNS infiltration that manifested as a complex presentation of persistent headaches in the context of multiple confounding factors, including a history of intractable migraines, recent discontinuation of Erenumab, elevated risk of idiopathic intracranial hypertension due to a body mass index of 45, and worsening herniation of a Chiari I malformation. Notably, the patient lacked the typical imaging features usually associated with CNS leukemia. This case highlights the need for proactive assessment of CNS involvement in AML patients who carry high-risk mutations and present with neurological symptoms. It further highlights the importance of having a high index of suspicion for CNS disease in AML patients presenting with headaches, even in the absence of classical radiographic findings of leptomeningeal spread.
No takes yet. Share an insight, caveat, or question.
Singla et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: